Partillion Bioscience Corp — Form D
Partillion Bioscience Corp of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-30. The offering totals $5.3M, of which $4.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-12-30
- Form: D
- Accession: 0001960451-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.3M
- Amount sold: $4.9M
- Remaining: $450K
- Investors: 12
- Date of first sale: 2022-12-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469239
Issuer
- Name: Partillion Bioscience Corp
- CIK: 0001960451
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2360 GLENDON AVE., LOS ANGELES, CA, 90064
- Phone: 707-529-3034
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Paul Conley | Director | Washington, DC |
| Joseph de Rutte | Director | Los Angeles, CA |
| Dino Di Carlo | Director | Los Angeles, CA |
| Eric Moessinger | Director | San Francisco, CA |
| Joseph de Rutte | Executive Officer | Los Angeles, CA |
More